menu search

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Viavi (viav) boosts production capacity with new az facility

The facility is expected to complement the strategic plan of Viavi (VIAV) to relocate its headquarters ...

November 18, 2022, 8:25 am

Browsi announces corporate rebrand reflecting expansion into video and becoming an all-in-one ad platform

Converging AI with groundbreaking video and display capabilities to provide full-stack advertising solutions for publishers Browsi Logo Browsi Logo NE...

November 17, 2022, 2:00 pm

Bux's uk 2021 revenue halved to £9.1m, losses deepen

Bux Financial Services Limited, the UK arm of BUX with ...

November 16, 2022, 11:41 am

Meta materials (mmat) stock climbs on new headquarters news

Meta Materials (NASDAQ: MMAT ) stock is on the move Tuesday as investors react to a couple of pieces of news about the company. To start with, there's...

November 15, 2022, 11:50 am

Alibaba's cainiao opens latam headquarters in brazil

The expansion comes as China's retail growth has slowed — Alibaba for the first time didn't release total sales for its Singles' Day shopping festiv...

November 13, 2022, 10:26 pm

Other firms take damage amid twitter chaos

It seems like Elon Musk strolled into the headquarters of Twitter holding a sink ages ago. In reality, ...

November 11, 2022, 7:18 pm

Sword health launches move, a first of its kind movement health solution that will empower members to start moving, stay moving, and live pain-free

Company expands its efforts in solving pain by pioneering a new solution that combines the clinical focus of physical therapy and the holistic approac...

November 10, 2022, 1:29 pm

Vicinity motor reveals positive construction update on its washington state manufacturing facility

Vicinity Motor Corp. (TSX-V:VMC) has provided an update on the construction of its new manufacturing facility in Ferndale, Washington, saying it antic...

November 9, 2022, 9:33 am

Orix corporation (ix) q2 2023 earnings call transcript

ORIX Corporation (NYSE:IX ) Q2 2023 Earnings Conference Call November 7, 2022 2:30 AM ET Company Participants Hitomaro Yano - Executive Officer, Head ...

November 7, 2022, 9:10 am

China evergrande lenders appoint receiver to seize hong kong headquarters: sources

Creditors of Chinese real estate developer Evergrande appoint a receiver to take the company's 26-story China Evergrande Centre in Hong Kong....

September 8, 2022, 4:40 pm

Evergrande crisis deepens as lender seizes headquarters - ft

China Evergrande Group's Hong Kong headquarters has been seized by a lender after the struggling Chines...

September 8, 2022, 6:40 am


Search within

Pages Search Results: